Results 261 to 270 of about 45,588 (281)

Phosphodiesterase Type 5 Inhibitors

2009
openaire   +1 more source

Phosphodiesterase type-5 inhibitors

2016
openaire   +1 more source

Effect of Phosphodiesterase-5 Inhibitor, Sildenafil (Viagra), in Animal Models of Airways Disease

American Journal of Respiratory and Critical Care Medicine, 2004
Kenneth J Broadley
exaly  

Effect of a cGMP-specific phosphodiesterase inhibitor on retinal function

European Journal of Pharmacology, 1998
Brigitte Bonhomme, Michel Doly
exaly  

The Phosphodiesterase 3 Inhibitor Cilostazol Dilates Large Cerebral Arteries in Humans without Affecting Regional Cerebral Blood Flow

Journal of Cerebral Blood Flow and Metabolism, 2004
Steffen Birk, Christina Kruuse, Peer Tfelt-Hansen   +2 more
exaly  

Evaluation of the phosphodiesterase 3 inhibitor ORG 9935 as a contraceptive in female macaques: initial trials

Contraception, 2010
Jeffrey T Jensen, Richard L Stouffer, Mary B Zelinski   +2 more
exaly  

OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study

Journal of the American Academy of Dermatology, 2016
Jon M Hanifin, Charles N Ellis, Ilona J Frieden   +2 more
exaly  

EEG abnormalities during treatment with tadalafil, a phosphodiesterase type 5 inhibitor

Neurological Research, 2009
Esra Okuyucu, Taskin Duman, Sadik Gorur   +2 more
exaly  

Ibudilast, a nonselective phosphodiesterase inhibitor, regulates Th1/Th2 balance and NKT cell subset in multiple sclerosis

Multiple Sclerosis Journal, 2004
Yuji Nakatsuji, Hikoaki Fukaura, Seiji Kikuchi   +2 more
exaly  

Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction

Expert Opinion on Investigational Drugs, 2010
Ma Limin, Wayne J G Hellström
exaly